RNA Analysis Transcriptomics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512244116

Publication Date:

December 3, 2024

Pages:

128

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Transcriptomics is听the analysis of the RNA transcripts produced by the genotype at a given time that provides a link between the genome, the proteome, and the cellular phenotype. It is a global approach, which together with genomics, proteomics, and metabolomics has evolved in recent years.
The global market for RNA Analysis Transcriptomics was estimated to be worth US$ 528.6 million in 2023 and is forecast to a readjusted size of US$ 1129 million by 2030 with a CAGR of 9.6% during the forecast period 2024-2030
Transcriptomics is听the analysis of the RNA transcripts produced by the genotype at a given time that provides a link between the genome, the proteome, and the cellular phenotype. It is a global approach, which together with genomics, proteomics, and metabolomics has evolved in recent years.
Report Scope
This report aims to provide a comprehensive presentation of the global market for RNA Analysis Transcriptomics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of RNA Analysis Transcriptomics by region & country, by Type, and by Application.
The RNA Analysis Transcriptomics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Analysis Transcriptomics.
Market Segmentation
By Company
Thermo Fisher Scientific
Bio-Rad Laboratories
Merck KGaA
Agilent Technologies
Illumina
QIAGEN N.V.
F. Hoffmann-La Roche
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech
Acobiom
GenXPro
CD Genomics
Promega Corporation
Lexogen
Cenix BioScience
Segment by Type:
Microarrays
Sequencing
Polymerase Chain Reaction (PCR)
RNA Interference
Segment by Application
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of RNA Analysis Transcriptomics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of RNA Analysis Transcriptomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of RNA Analysis Transcriptomics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 RNA Analysis Transcriptomics Product Introduction
1.2 Global RNA Analysis Transcriptomics Market Size Forecast
1.3 RNA Analysis Transcriptomics Market Trends & Drivers
1.3.1 RNA Analysis Transcriptomics Industry Trends
1.3.2 RNA Analysis Transcriptomics Market Drivers & Opportunity
1.3.3 RNA Analysis Transcriptomics Market Challenges
1.3.4 RNA Analysis Transcriptomics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global RNA Analysis Transcriptomics Players Revenue Ranking (2023)
2.2 Global RNA Analysis Transcriptomics Revenue by Company (2019-2024)
2.3 Key Companies RNA Analysis Transcriptomics Manufacturing Base Distribution and Headquarters
2.4 Key Companies RNA Analysis Transcriptomics Product Offered
2.5 Key Companies Time to Begin Mass Production of RNA Analysis Transcriptomics
2.6 RNA Analysis Transcriptomics Market Competitive Analysis
2.6.1 RNA Analysis Transcriptomics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by RNA Analysis Transcriptomics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Analysis Transcriptomics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Microarrays
3.1.2 Sequencing
3.1.3 Polymerase Chain Reaction (PCR)
3.1.4 RNA Interference
3.2 Global RNA Analysis Transcriptomics Sales Value by Type
3.2.1 Global RNA Analysis Transcriptomics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global RNA Analysis Transcriptomics Sales Value, by Type (2019-2030)
3.2.3 Global RNA Analysis Transcriptomics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Academic & Research Institutes
4.1.2 Pharmaceutical & Biotechnology Companies
4.1.3 Hospitals
4.2 Global RNA Analysis Transcriptomics Sales Value by Application
4.2.1 Global RNA Analysis Transcriptomics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global RNA Analysis Transcriptomics Sales Value, by Application (2019-2030)
4.2.3 Global RNA Analysis Transcriptomics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global RNA Analysis Transcriptomics Sales Value by Region
5.1.1 Global RNA Analysis Transcriptomics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global RNA Analysis Transcriptomics Sales Value by Region (2019-2024)
5.1.3 Global RNA Analysis Transcriptomics Sales Value by Region (2025-2030)
5.1.4 Global RNA Analysis Transcriptomics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America RNA Analysis Transcriptomics Sales Value, 2019-2030
5.2.2 North America RNA Analysis Transcriptomics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe RNA Analysis Transcriptomics Sales Value, 2019-2030
5.3.2 Europe RNA Analysis Transcriptomics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific RNA Analysis Transcriptomics Sales Value, 2019-2030
5.4.2 Asia Pacific RNA Analysis Transcriptomics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America RNA Analysis Transcriptomics Sales Value, 2019-2030
5.5.2 South America RNA Analysis Transcriptomics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa RNA Analysis Transcriptomics Sales Value, 2019-2030
5.6.2 Middle East & Africa RNA Analysis Transcriptomics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions RNA Analysis Transcriptomics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions RNA Analysis Transcriptomics Sales Value
6.3 United States
6.3.1 United States RNA Analysis Transcriptomics Sales Value, 2019-2030
6.3.2 United States RNA Analysis Transcriptomics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States RNA Analysis Transcriptomics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe RNA Analysis Transcriptomics Sales Value, 2019-2030
6.4.2 Europe RNA Analysis Transcriptomics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe RNA Analysis Transcriptomics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China RNA Analysis Transcriptomics Sales Value, 2019-2030
6.5.2 China RNA Analysis Transcriptomics Sales Value by Type (%), 2023 VS 2030
6.5.3 China RNA Analysis Transcriptomics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan RNA Analysis Transcriptomics Sales Value, 2019-2030
6.6.2 Japan RNA Analysis Transcriptomics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan RNA Analysis Transcriptomics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea RNA Analysis Transcriptomics Sales Value, 2019-2030
6.7.2 South Korea RNA Analysis Transcriptomics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea RNA Analysis Transcriptomics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia RNA Analysis Transcriptomics Sales Value, 2019-2030
6.8.2 Southeast Asia RNA Analysis Transcriptomics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia RNA Analysis Transcriptomics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India RNA Analysis Transcriptomics Sales Value, 2019-2030
6.9.2 India RNA Analysis Transcriptomics Sales Value by Type (%), 2023 VS 2030
6.9.3 India RNA Analysis Transcriptomics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific RNA Analysis Transcriptomics Products, Services and Solutions
7.1.4 Thermo Fisher Scientific RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Bio-Rad Laboratories
7.2.1 Bio-Rad Laboratories Profile
7.2.2 Bio-Rad Laboratories Main Business
7.2.3 Bio-Rad Laboratories RNA Analysis Transcriptomics Products, Services and Solutions
7.2.4 Bio-Rad Laboratories RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.2.5 Bio-Rad Laboratories Recent Developments
7.3 Merck KGaA
7.3.1 Merck KGaA Profile
7.3.2 Merck KGaA Main Business
7.3.3 Merck KGaA RNA Analysis Transcriptomics Products, Services and Solutions
7.3.4 Merck KGaA RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.3.5 Agilent Technologies Recent Developments
7.4 Agilent Technologies
7.4.1 Agilent Technologies Profile
7.4.2 Agilent Technologies Main Business
7.4.3 Agilent Technologies RNA Analysis Transcriptomics Products, Services and Solutions
7.4.4 Agilent Technologies RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.4.5 Agilent Technologies Recent Developments
7.5 Illumina
7.5.1 Illumina Profile
7.5.2 Illumina Main Business
7.5.3 Illumina RNA Analysis Transcriptomics Products, Services and Solutions
7.5.4 Illumina RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.5.5 Illumina Recent Developments
7.6 QIAGEN N.V.
7.6.1 QIAGEN N.V. Profile
7.6.2 QIAGEN N.V. Main Business
7.6.3 QIAGEN N.V. RNA Analysis Transcriptomics Products, Services and Solutions
7.6.4 QIAGEN N.V. RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.6.5 QIAGEN N.V. Recent Developments
7.7 F. Hoffmann-La Roche
7.7.1 F. Hoffmann-La Roche Profile
7.7.2 F. Hoffmann-La Roche Main Business
7.7.3 F. Hoffmann-La Roche RNA Analysis Transcriptomics Products, Services and Solutions
7.7.4 F. Hoffmann-La Roche RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.7.5 F. Hoffmann-La Roche Recent Developments
7.8 Danaher Corporation
7.8.1 Danaher Corporation Profile
7.8.2 Danaher Corporation Main Business
7.8.3 Danaher Corporation RNA Analysis Transcriptomics Products, Services and Solutions
7.8.4 Danaher Corporation RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.8.5 Danaher Corporation Recent Developments
7.9 Fluidigm Corporation
7.9.1 Fluidigm Corporation Profile
7.9.2 Fluidigm Corporation Main Business
7.9.3 Fluidigm Corporation RNA Analysis Transcriptomics Products, Services and Solutions
7.9.4 Fluidigm Corporation RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.9.5 Fluidigm Corporation Recent Developments
7.10 Eurofins Scientific
7.10.1 Eurofins Scientific Profile
7.10.2 Eurofins Scientific Main Business
7.10.3 Eurofins Scientific RNA Analysis Transcriptomics Products, Services and Solutions
7.10.4 Eurofins Scientific RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.10.5 Eurofins Scientific Recent Developments
7.11 Sequentia Biotech
7.11.1 Sequentia Biotech Profile
7.11.2 Sequentia Biotech Main Business
7.11.3 Sequentia Biotech RNA Analysis Transcriptomics Products, Services and Solutions
7.11.4 Sequentia Biotech RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.11.5 Sequentia Biotech Recent Developments
7.12 Acobiom
7.12.1 Acobiom Profile
7.12.2 Acobiom Main Business
7.12.3 Acobiom RNA Analysis Transcriptomics Products, Services and Solutions
7.12.4 Acobiom RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.12.5 Acobiom Recent Developments
7.13 GenXPro
7.13.1 GenXPro Profile
7.13.2 GenXPro Main Business
7.13.3 GenXPro RNA Analysis Transcriptomics Products, Services and Solutions
7.13.4 GenXPro RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.13.5 GenXPro Recent Developments
7.14 CD Genomics
7.14.1 CD Genomics Profile
7.14.2 CD Genomics Main Business
7.14.3 CD Genomics RNA Analysis Transcriptomics Products, Services and Solutions
7.14.4 CD Genomics RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.14.5 CD Genomics Recent Developments
7.15 Promega Corporation
7.15.1 Promega Corporation Profile
7.15.2 Promega Corporation Main Business
7.15.3 Promega Corporation RNA Analysis Transcriptomics Products, Services and Solutions
7.15.4 Promega Corporation RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.15.5 Promega Corporation Recent Developments
7.16 Lexogen
7.16.1 Lexogen Profile
7.16.2 Lexogen Main Business
7.16.3 Lexogen RNA Analysis Transcriptomics Products, Services and Solutions
7.16.4 Lexogen RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.16.5 Lexogen Recent Developments
7.17 Cenix BioScience
7.17.1 Cenix BioScience Profile
7.17.2 Cenix BioScience Main Business
7.17.3 Cenix BioScience RNA Analysis Transcriptomics Products, Services and Solutions
7.17.4 Cenix BioScience RNA Analysis Transcriptomics Revenue (US$ Million) & (2019-2024)
7.17.5 Cenix BioScience Recent Developments
8 Industry Chain Analysis
8.1 RNA Analysis Transcriptomics Industrial Chain
8.2 RNA Analysis Transcriptomics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 RNA Analysis Transcriptomics Sales Model
8.5.2 Sales Channel
8.5.3 RNA Analysis Transcriptomics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Thermo Fisher Scientific
Bio-Rad Laboratories
Merck KGaA
Agilent Technologies
Illumina
QIAGEN N.V.
F. Hoffmann-La Roche
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech
Acobiom
GenXPro
CD Genomics
Promega Corporation
Lexogen
Cenix BioScience

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂